Eventide Asset Management LLC grew its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 2.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 70,702 shares of the biotechnology company’s stock after purchasing an additional 1,598 shares during the period. Eventide Asset Management LLC owned approximately 0.09% of Axon Enterprise worth $40,159,000 at the end of the most recent reporting period.
Several other large investors have also bought and sold shares of the company. New Millennium Group LLC acquired a new stake in Axon Enterprise in the 3rd quarter valued at about $29,000. Darwin Wealth Management LLC acquired a new stake in Axon Enterprise in the 2nd quarter valued at about $37,000. Creative Financial Designs Inc. ADV acquired a new stake in Axon Enterprise in the 4th quarter valued at about $28,000. Sound Income Strategies LLC lifted its holdings in Axon Enterprise by 550.0% in the 4th quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock valued at $30,000 after acquiring an additional 44 shares during the last quarter. Finally, Camelot Portfolios LLC acquired a new stake in Axon Enterprise in the 4th quarter valued at about $30,000. Institutional investors own 79.08% of the company’s stock.
Insiders Place Their Bets
In related news, insider Elizabeth Reid Coughlin sold 1,554 shares of the stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $485.00, for a total value of $753,690.00. Following the completion of the transaction, the insider owned 34,024 shares in the company, valued at $16,501,640. This trade represents a 4.37% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, President Joshua Isner sold 13,000 shares of the stock in a transaction on Friday, June 5th. The shares were sold at an average price of $488.45, for a total value of $6,349,850.00. Following the completion of the transaction, the president owned 169,125 shares of the company’s stock, valued at $82,609,106.25. This trade represents a 7.14% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 39,344 shares of company stock worth $19,267,315 over the last three months. Company insiders own 4.20% of the company’s stock.
Wall Street Analyst Weigh In
Check Out Our Latest Research Report on AXON
Axon Enterprise Trading Down 1.0%
NASDAQ:AXON opened at $441.73 on Friday. The company has a quick ratio of 1.93, a current ratio of 2.27 and a debt-to-equity ratio of 0.49. Axon Enterprise, Inc has a 1-year low of $339.01 and a 1-year high of $885.91. The firm has a market capitalization of $35.60 billion, a price-to-earnings ratio of 177.40, a price-to-earnings-growth ratio of 8.03 and a beta of 1.45. The stock has a fifty day simple moving average of $410.34 and a 200 day simple moving average of $489.19.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share for the quarter, beating analysts’ consensus estimates of $1.60 by $0.01. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The business had revenue of $807.35 million during the quarter, compared to analyst estimates of $778.91 million. During the same quarter last year, the company posted $1.47 EPS. Axon Enterprise’s revenue for the quarter was up 33.7% on a year-over-year basis. Sell-side analysts forecast that Axon Enterprise, Inc will post 1.82 earnings per share for the current year.
About Axon Enterprise
Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.
Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.
Featured Stories
- Five stocks we like better than Axon Enterprise
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
